Home
/
CLOVER HEALTH INVESTMENTS, CORP. /DE
/
Financials
/
Quarterly
CLOVER HEALTH INVESTMENTS, CORP. /DE — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that CLOVER HEALTH INVESTMENTS, CORP. /DE filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$496.65M
Nov 7, 2025
Q2
2025
Jun 30, 2025
$477.62M
Aug 8, 2025
Q1
2025
Mar 31, 2025
$462.33M
May 9, 2025
Q3
2025
Sep 30, 2024
$330.99M
Nov 7, 2025
Q2
2025
Jun 30, 2024
$356.26M
Aug 8, 2025
Q1
2025
Mar 31, 2024
$346.92M
May 9, 2025
Q3
2024
Sep 30, 2023
$306.03M
Nov 8, 2024
Q2
2024
Jun 30, 2023
$320.14M
Aug 8, 2024
Q1
2024
Mar 31, 2023
$321.99M
May 7, 2024
Q3
2023
Sep 30, 2022
$856.82M
Nov 6, 2023
Q2
2023
Jun 30, 2022
$846.70M
Aug 8, 2023
Q1
2023
Mar 31, 2022
$874.38M
May 9, 2023
Q3
2022
Sep 30, 2021
$427.16M
Nov 7, 2022
Q2
2022
Jun 30, 2021
$412.47M
Aug 8, 2022
Q1
2022
Mar 31, 2021
$200.33M
May 9, 2022
Q3
2021
Sep 30, 2020
$169.07M
Nov 9, 2021
Q2
2021
Jun 30, 2020
$172.08M
Aug 11, 2021
Q1
2021
Mar 31, 2020
$165.51M
May 17, 2021
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($24.38M)
Nov 7, 2025
Q2
2025
Jun 30, 2025
($10.58M)
Aug 8, 2025
Q3
2025
Jun 30, 2025
($10.58M)
Nov 7, 2025
Q1
2025
Mar 31, 2025
($1.27M)
May 9, 2025
Q2
2025
Mar 31, 2025
($1.27M)
Aug 8, 2025
Q3
2025
Mar 31, 2025
($1.27M)
Nov 7, 2025
Q3
2025
Sep 30, 2024
($9.16M)
Nov 7, 2025
Q3
2025
Jun 30, 2024
$7.41M
Nov 7, 2025
Q2
2025
Jun 30, 2024
$7.41M
Aug 8, 2025
Q2
2025
Mar 31, 2024
($19.17M)
Aug 8, 2025
Q3
2025
Mar 31, 2024
($19.17M)
Nov 7, 2025
Q1
2025
Mar 31, 2024
($19.17M)
May 9, 2025
Q3
2024
Sep 30, 2023
($41.47M)
Nov 8, 2024
Q2
2024
Jun 30, 2023
($28.81M)
Aug 8, 2024
Q3
2024
Jun 30, 2023
($28.81M)
Nov 8, 2024
Q3
2024
Mar 31, 2023
($72.61M)
Nov 8, 2024
Q1
2024
Mar 31, 2023
($72.61M)
May 7, 2024
Q2
2024
Mar 31, 2023
($72.61M)
Aug 8, 2024
Q3
2023
Sep 30, 2022
($75.49M)
Nov 6, 2023
Q2
2023
Jun 30, 2022
($104.36M)
Aug 8, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($24.38M)
Nov 7, 2025
Q2
2025
Jun 30, 2025
($10.56M)
Aug 8, 2025
Q1
2025
Mar 31, 2025
($1.27M)
May 9, 2025
Q3
2025
Sep 30, 2024
($8.79M)
Nov 7, 2025
Q2
2025
Jun 30, 2024
$7.19M
Aug 8, 2025
Q1
2025
Mar 31, 2024
($22.70M)
May 9, 2025
Q3
2024
Sep 30, 2023
($33.62M)
Nov 8, 2024
Q2
2024
Jun 30, 2023
($28.88M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($79.70M)
May 7, 2024
Q3
2023
Sep 30, 2022
($74.10M)
Nov 6, 2023
Q2
2023
Jun 30, 2022
($102.73M)
Aug 8, 2023
Q1
2023
Mar 31, 2022
($87.48M)
May 9, 2023
Q3
2022
Sep 30, 2021
($149.25M)
Nov 7, 2022
Q2
2022
Jun 30, 2021
($181.86M)
Aug 8, 2022
Q1
2022
Mar 31, 2021
($119.09M)
May 9, 2022
Q3
2021
Sep 30, 2020
($21.62M)
Nov 9, 2021
Q2
2021
Jun 30, 2020
$23.17M
Aug 11, 2021
Q1
2021
Mar 31, 2020
($26.63M)
May 17, 2021